戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 single nucleotide incorporation catalyzed by HIV reverse transcriptase.
2 centrations and temperatures and apply it to HIV reverse transcriptase.
3 strate or zalcitabine, an inhibitor used for HIV reverse transcriptase.
4  effectively depletes the dNTP substrates of HIV reverse transcriptase.
5 han the corresponding reaction observed with HIV reverse transcriptase.
6  toxicity of anti-retroviral drugs targeting HIV reverse transcriptase.
7 ymerase, T7 DNA-dependent RNA polymerase and HIV reverse transcriptase.
8 anism of RNase H and drug design targeted to HIV reverse transcriptase.
9 IV activity, and they also failed to inhibit HIV reverse transcriptase.
10 ncy virus, type I (HIV) RNase H, a domain of HIV reverse transcriptase.
11 recognized by the ribonuclease H function of HIV reverse transcriptase.
12 merase-alpha and polymerase-beta, as well as HIV reverse transcriptase.
13 a significant and dose-dependent increase of HIV reverse transcriptase activity in human blood monocy
14 role of induced fit in enzyme specificity of HIV reverse transcriptase and many other enzymes.
15                            Expression of the HIV reverse transcriptase and other essential viral enzy
16 ynucleosides, which are potent inhibitors of HIV reverse transcriptase and other viral DNA polymerase
17  based on a reversibly linked combination of HIV reverse transcriptase and protease inhibitors.
18                                          The HIV reverse transcriptase and protease sequence database
19                                          The HIV Reverse Transcriptase and Protease Sequence Database
20 delity of DENV polymerase is comparable with HIV reverse transcriptase and the poliovirus polymerase.
21 , apply it to family A and B polymerases and HIV reverse transcriptase, and discuss factors that may
22  hybrid decreases the rate of both human and HIV reverse transcriptase-associated RNase H-mediated cl
23  of published crystal structures showed that HIV reverse transcriptase binds only two metal ions prio
24                                Inhibitors of HIV reverse transcriptase, but not integrase, abrogated
25 tor of HBV and human immunodeficiency virus (HIV) reverse transcriptases, but substitutions of isoleu
26             The isolated RNase H domain from HIV reverse transcriptase can be expressed independently
27                                              HIV reverse transcriptase could elongate DNA primers aft
28        Here we provide an in-depth review of HIV reverse transcriptase, current RT inhibitors, novel
29               The RNA/DNA hybrid produced by HIV reverse transcriptase during (-) strand synthesis pr
30  SARS-CoV-2 RNA-dependent RNA polymerase and HIV reverse transcriptase, enabling live-cell RNA imagin
31 of the class I MHC-HLA2 complex bound to the HIV reverse transcriptase epitope, ILKEPVHGV, and in the
32  were determined by analyzing 155,462 single HIV reverse transcriptase gene (RT) and 6,985 vif sequen
33        Sequence analysis of a portion of the HIV reverse transcriptase gene demonstrated a disproport
34 udies here show that at the same shift motif HIV reverse transcriptase generates -1 and +1 indels wit
35                       Structural modeling of HIV reverse transcriptase has permitted key insights int
36 tion of functional TNA aptamers that bind to HIV reverse transcriptase (HIV RT) with K(D)'s of ~0.4-4
37  compound 35 in the active site of wild type HIV reverse transcriptase (HIV-RT).
38  bacteriophage T7 DNA polymerase (T7(-)) and HIV reverse transcriptase (HIV-RT).
39  essential for the synthesis of viral DNA by HIV reverse transcriptase (HIV-RT).
40 en developed for determining the activity of HIV reverse transcriptase (HIV-RT).
41 d to select ssDNA aptamers with affinity for HIV reverse transcriptase (HIVRT).
42 ninyl phenyl ester prodrug of the nucleotide HIV reverse transcriptase inhibitor tenofovir (TFV; 9-[(
43 istant virus, next generation non-nucleoside HIV reverse transcriptase inhibitors (NNRTIs) with impro
44 everal lavendamycins were found to be potent HIV reverse transcriptase inhibitors with very low toxic
45 e chain in RB69 DNA polymerase (Arg-482) and HIV reverse transcriptase (Lys-65) were previously obser
46 dition, the optical control mechanism of the HIV reverse transcriptase-mediated RT process was elucid
47                 Non-nucleoside inhibitors of HIV reverse transcriptase (NNRTIs), albeit not the mains
48  inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (NNRTIs).
49 atrix peptide (a model recall antigen) or an HIV reverse transcriptase peptide (a model novel antigen
50                                              HIV reverse transcriptase plays a central role in viral
51 ted HIV strains resistant to drugs targeting HIV reverse transcriptase, protease, integrase, and core
52                  Of three enzymes encoded by HIV-reverse transcriptase, protease, and integrase-only
53 of toxicity to human cells, incorporation by HIV reverse transcriptase, resistance to repair when inc
54           In vitro reaction conditions using HIV reverse transcriptase (RT) and nucleocapsid protein
55 clovir in HIV-infected cells is validated as HIV reverse transcriptase (RT) by the emergence of the R
56                             The mechanism of HIV reverse transcriptase (RT) catalyzed strand transfer
57 V naturally contain high uracil content, and HIV reverse transcriptase (RT) does not distinguish betw
58 mation systems, we have examined variants of HIV reverse transcriptase (RT) for their ability to synt
59 e analogues leads to a novel class of potent HIV reverse transcriptase (RT) inhibitors, alpha-carboxy
60                                              HIV reverse transcriptase (RT) is an enzyme that plays a
61 s (NNRTIs) with activity against variants of HIV reverse transcriptase (RT) is crucial for overcoming
62              Structural studies of authentic HIV reverse transcriptase (RT) suggest a role for the p5
63                                   Binding of HIV reverse transcriptase (RT) to unique substrates that
64                 Strand transfer catalyzed by HIV reverse transcriptase (RT) was examined.
65                           Deep sequencing of HIV reverse transcriptase (RT) was performed (Roche/454)
66                                  Modeling of HIV reverse transcriptase (RT) with RNA/DNA in its RNase
67 rimer for synthesis of the (+) DNA strand by HIV reverse transcriptase (RT), and which is not digeste
68 n(2+), and Zn(2+) have been shown to inhibit HIV reverse transcriptase (RT), presumably by competitiv
69                          The dimerization of HIV reverse transcriptase (RT), required to obtain the a
70 ive antiretroviral (HAART) therapy targeting HIV reverse transcriptase (RT).
71 ranslocation of triazoles into the P-site of HIV reverse transcriptase (RT).
72 phate (rac-1h-TP) for its ability to inhibit HIV reverse transcriptase (RT).
73 tion of human immunodeficiency virus type 1 (HIV) reverse transcriptase (RT) and protease (PT) sequen
74 riation in the human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease enzymes, th
75 riation in the human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease enzymes, th
76 d drug-related human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease sequence va
77 ctions between human immunodeficiency virus (HIV) reverse transcriptase (RT) and structures mimicking
78  Inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT) are widely used in the t
79                Human immunodeficiency virus (HIV) reverse transcriptase (RT) associated ribonuclease
80 suggested that human immunodeficiency virus (HIV) reverse transcriptase (RT) binds to the 5' end of R
81 he fidelity of human immunodeficiency virus (HIV) reverse transcriptase (RT) has been a subject of in
82                Human immunodeficiency virus (HIV) reverse transcriptase (RT)-associated ribonuclease
83 , derived from human immunodeficiency virus (HIV)-reverse transcriptase (RT) residues 309-317, are mo
84                                              HIV-reverse transcriptase (RT) extended the DNA and clea
85 identified through a virtual screening using HIV-reverse transcriptase (RT), adenylate/guanylate kina
86                   Single turnover studies on HIV reverse transcriptase suggest that nucleoside analog
87 work ideas to build a detailed model for the HIV reverse transcriptase that is consistent with existi
88  readily incorporated into a DNA template by HIV reverse transcriptase to act as a DNA chain terminat
89  predictable drug resistance mutation in the HIV reverse transcriptase to label and track cells infec
90                     With in-house assays for HIV reverse transcriptase, we evaluated the yield of gen
91                                HTBS recruits HIV reverse transcriptase, which nucleates DNA synthesis
92        The triphosphate (N-MCD4TTP) inhibits HIV reverse transcriptase with a 10-fold higher IC(50) t
93 cell) extracts, and they were substrates for HIV-reverse transcriptase without being substrates for D